Ginseng, a perennial plant belonging to the genus Panax of the Araliaceae family, is well known for its medicinal properties that help alleviate pathological symptoms, promote health, and prevent potential diseases. Among the active ingredients of ginseng are saponins, most of which are glycosides of triterpenoid aglycones. So far, numerous saponins have been reported as components of Panax ginseng, also known as Korean ginseng. Herein, we summarize available information about 112 saponins related to P. ginseng; >80 of them are isolated from raw or processed ginseng, and the others are acid/base hydrolysates, semisynthetic saponins, or metabolites.
Introduction
Ginseng has been one of the most important components in a number of East Asian herbal remedies. In fact, the term ginseng, without any modifier, refers particularly to the species Panax ginseng Meyer or sometimes even more specifically to the root of the plant species. As the name ginseng carries authority and veneration in East Asian medicine, other plants that have some properties in common with P. ginseng have been allegedly called "ginseng". Eventually, ginseng has become a blanket term that encompasses >10 species of perennial plants belonging to the genus Panax of the family Araliaceae [1, 2] . Currently, 14 plants, including 12 species and two infraspecific taxa, have been recognized as members of the genus Panax, as shown in Table 1 [3] . Some of the Panax plants have common names, which stem from their countries of origin: P. ginseng, Panax japonicus, Panax notoginseng, Panax quinquefolius, and Panax vietnamensis are also called Korean ginseng, Japanese ginseng, Chinese ginseng, American ginseng, and Vietnamese ginseng, respectively. Of the Panax plants, Korean ginseng, Chinese ginseng, and American ginseng have been commercially cultivated; Vietnamese ginseng has recently been introduced for agriculture. Most ginseng species are native to Asia, especially East Asia. Thus, the use of equivocal names, such as Asian ginseng that often refers to P. ginseng, is discouraged.
While the variety of species renders some pharmacological effects specific to certain species, ginseng, in general, displays restorative, tonic, and revitalizing properties [4] . Thus far, >6,000 articles regarding the traditional uses, chemical constituents, and biological and pharmacological effects of ginseng have been published since Petkov [5] reported the pharmacological properties of P. ginseng extracts in the 1950s. Such pharmacological activities of ginseng have been found to be mainly attributed to ginseng saponins, also known as ginsenosides [6e11] .
Since the first isolation of six ginsenosides from P. ginseng in the 1960s [12] , plenty of ginsenosides have been isolated and identified from the species. In this review, we recapitulate the chemical structures, molecular masses, and monoisotopic masses of saponins from various parts of P. ginseng, including roots, flower buds, fruits, and leaves. In addition, we furnish available information about artifactual saponins formed during physicochemical and/or biological treatment and compounds synthesized from saponins isolated from P. ginseng.
Classification of ginseng saponins according to their genin structures
Most ginseng saponins are believed to be biosynthesized from 2,3-oxidosqualene, which is also the precursor of b-sitosterol, a steroid commonly found in plants [13] . It has been suggested that the action of three different enzymes on 2,3-oxidosqualene leads to the formation of cycloartenol, dammarenediol-II, and b-amyrin, the latter two of which are eventually biotransformed into ginseng saponins. Fig. 1 shows the proposed biosynthetic pathway of ginseng saponins and b-sitosterol. Dammarenediol-II is the precursor of dammarane-type saponins, including ginsenosides Rb1, Rb2, Re, and Rg1, which account for a significant portion of saponins found in ginseng species. Dammarane-type saponins are further classified into various groups. By contrast, oleanane-type saponins are biosynthesized from b-amyrin. In P. ginseng, however, oleanane-type saponins other than ginsenoside Ro are rare and often practically undetectable. Table 2 [14e67] displays the molecular formulas, molecular masses, monoisotopic masses, and parts of ginseng saponins, isolated from or related to P. ginseng, that are used. We categorize the ginseng saponins based upon the position of hydroxyl group(s) and/or double bond(s) of their genins.
Protopanaxadiol, protopanaxatriol, and their glycosides
As shown in Fig. 1 , dammarenediol-II is hydroxylated to protopanaxadiol (PPD), 3b,12b,20-trihydroxydammar-24-ene. Ultimately, a number of saponins are biosynthesized by Oglycosylation of PPD that involves the attachment of saccharide(s) to C-3 and/or C-20. Typical PPD-type saponins include ginsenosides Rb1, Rb2, Rc, and Rd, which are found in the roots [19, 20] , flower buds [21] , and leaves [21] of P. ginseng.
PPD may further be hydroxylated to protopanaxatriol (PPT), 3b,6a,12b,20-tetrahydroxydammar-24-ene. A variety of saponins are biosynthesized by O-glycosylation of PPT that involves the attachment of saccharide(s) to C-6 and/or C-20. Typically, the hydroxyl group at C-3 remains free in PPT-type ginsenosides. The two most abundant PPT-type saponins in P. ginseng are ginsenosides Re and Rg1. Fig. 2A illustrates the structures of PPD-and PPT-type saponins. While most naturally occurring ginsenosides are of the (S)-configuration at C-20, some artifactual ginsenosides exist in two epimeric forms at the carbon.
Peroxidation products of PPD-and PPT-type saponins
Some saponins isolated from the flower buds of P. ginseng have an aglycone that is believed to be produced via the peroxidation of PPD or PPT [68] . In most cases, the peroxidation occurs at or around the double bond between C-24 and C-25, and eventually leads to various structures. Fig. 2B , C show the structures of ginsenosides whose genin appears to be produced via the peroxidation of PPD or PPT. Fig. 2B-(a) shows the structures of some saponins that have a hydroperoxyl group at C-24 and a double bond between C-25 and C-26. Fig. 2B -(b) contains the genin structure that has a hydroxyl group at C-24, which would be reduced from the hydroperoxyl group shown in Fig. 2B-(a) . In addition, Fig. 2B -(c) shows the structure of floralginsenoside Ta, a glycoside of 3b,6a,12b,20-tetrahydroxydammar-24-one-25-ene, which may be considered to be formed by the dehydration of floralginsenoside Ka, whose structure is illustrated in Fig. 2B -(a). In a similar fashion, Fig. 2C-(a,b) show the structures of ginseng saponins whose genin has a hydroperoxyl group and a hydroxyl group, respectively, at C-25 and a double bond between C-23 and C-24. While geometric isomerism is possible in compounds with a double bond between C-23 and C-24, most of those reported are the (E)-form isomers rather than the (Z)-form. In addition, Fig. 2C -(c) illustrates the structures of ginsenosides whose genin has a hydroxyl group either at C-26 or at C-27, which would be reduced from the hydroperoxyl group formed around the double bond between C-24 and C-25.
Cleavage products of PPD-and PPT-type saponins
The oxidative cleavage of the double bond of some saponins yields an aldehyde with three fewer carbon atoms, that is, 3b,12b,20-trihydroxy-25,26,27-trinordammar-24-al, and its derivatives, which are found mainly in the flower buds of ginseng. Fig. 2D-(a) shows the structures of ginsenosides whose genin is considered to be formed by the oxidative cleavage of the double bond of PPD or 23-hydroxyprotopanaxadiol. Fig. 2D-(b) shows the structure of floralginsenoside Tb, whose genin is an acetal of 3b,6a,12b,20-tetrahydroxy-25,26,27-trinordammar-24-al, which appears to be formed from PPT.
Hydration and dehydration products of PPD-and PPT-type saponins
The hydration of the double bond of PPD or PPT yields a dammarane derivative with a hydroxyl group at C-25 and no double bond. Fig. 2E illustrates the structures of the saponins 25-hydroxyprotopanaxadiol and 25-hydroxyprotopanaxatriol.
Most PPD-and PPT-type ginsenosides tend to be deglycosylated and dehydrated at C-20 when steamed or heat processed. The resultant double bond is formed either between C-20 and C-21 or between C-20 and C-22. In the latter case, the (E)/(Z) geometric isomerism exists. Fig. 3 illustrates the probable pathways of the formation of artifactual saponins owing to heating. Fig. 2F shows the structures of saponins that are considered to be the dehydration products of the PPD-and PPT-type saponins shown in Fig. 2A. 
Saponins with an epoxy group
The acid hydrolysis of a PPD-type and a PPT-type saponin leads to the formation of a six-membered ring containing oxygen, yielding panaxadiol, 3b,12b-dihydroxy-20,25-epoxydammarane, and panaxatriol, 3b,6a,12b-trihydroxy-20,25-epoxydammarane, respectively. Fig. 2G-(a) shows the structures of panaxadiol and panaxatriol. Moreover, some saponins are derivatives of 3b,6a,20- 1) The calculations are based upon the latest atomic mass data from the International Union of Pure and Applied Chemistry (IUPAC) [67] . dihydroxy-12,23-epoxydammar-24-ene or 6a,25-dihydroxy-20,24-epoxydammar-3,12-dione. Fig. 2G-(b,c) show the structures of saponins with an epoxy group between C-12 and C-23 and between C-20 and C-24, respectively.
Saponins isolated from P. ginseng with other aglycones
The genins of some saponins isolated from P. ginseng are different from those aforementioned. Fig. 2H, I illustrate the structures of ginsenosides with other backbones.
Synthetic saponins
Synthetic compounds whose structures are related to saponins isolated from P. ginseng have been reported. In most cases, derivatives of dammarane are synthesized from isolated ginsenosides to enhance biological activity. Indeed, several acylated saponins have been found to have antitumor activity [61, 63] . In addition, some derivatives of ocotillol have shown myocardial ischemia protective effect [64] . Fig. 2J illustrates the structures of some synthetic saponins.
Saponin metabolites
Most ginsenosides are metabolized by intestinal bacteria. Fig. 4 shows the suggested metabolic pathways of PPD-and PPT-type ginsenosides. The former is deglycosylated at C-3 and transformed to either M1 (compound K) or PPD. By contrast, the latter is deglycosylated at C-6 and/or C-20, and eventually transformed to PPT. Fig. 2K shows the structures of the saponin metabolites that have not been reported as being present in raw or processed ginseng.
Concluding remarks
Ginseng is well known for its beneficial biological effects on the human body. While the plant contains various ingredients, ginsenosides play a more significant role in exerting pharmacological actions than any other constituents. Of the great number of ginsenosides present in P. ginseng, fewer than 10 account for most ginsenoside contents. In particular, ginsenosides Rb1, Rb2, Rc, Rd, Re, Rf, and Rg1 are most abundant in the roots of raw ginseng. Intriguingly, chemical reactions during the processing of ginseng, such as oxidation, hydrolysis, and/or dehydration, lead to the formation of artifactual compounds, which often have enhanced biological activities. Besides, orally administered ginsenosides undergo biotransformations in the gastrointestinal tract, and some metabolites produced by the action of bacteria have structures different from those of naturally occurring ginsenosides. Here, >100 ginsenosides have been classified according to their structural features.
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